Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Amarantus Bioscience Holdings, Inc (AMBS)

-Other OTC
0.07 Down 0.00(0.43%) Apr 17, 3:59PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2012Dec 31, 2011Dec 31, 2010
Total Revenue -   224   192  
Cost of Revenue -   -   -  
Gross Profit -   224   192  
Operating Expenses
Research Development584  1,178  490  
Selling General and Administrative3,506  2,786  924  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (4,090) (3,740) (1,223)
Income from Continuing Operations
Total Other Income/Expenses Net473  315  94  
Earnings Before Interest And Taxes(3,617)(3,425)(1,128)
Interest Expense1,518  1,015  79  
Income Before Tax(5,136)(4,440)(1,208)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(5,136)(4,440)(1,208)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (5,136) (4,440) (1,208)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (5,136) (4,440) (1,208)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.